Wang Y, Xue Y, Xu H, Zhu Q, Qin K, He Z, Huang A, Mu M, Tao X (2025) Pediococcus acidilactici Y01 reduces HFD-induced obesity via altering gut microbiota and metabolomic profiles and modulating adipose tissue macrophage M1/M2 polarization
The studys authors noted that increases in GH and IGF-I levels produced by CJC-1295 DAC were dose-dependent, meaning that in the context of that particular study, higher doses of CJC-1295 produced greater rises in GH and IGF-1 levels than lower doses
Safety, Legal Status, and Why It Matters CJC 1295 is currently classified as a research chemical in most countries, including the United States
The FDA has not approved an NDA for ipamorelin, so no FDA label with hepatic-impairment language exists
Pharmaceutical-grade sourcing and proper monitoring make this a very safe therapy